Aparna Raval, Phd Email & Phone Number

Redwood City, CA, US

Translational Research in Cancer Immunotherapy

Lawrence Township, NJ, US

• Translational Medicine Head, Multiple Myeloma.
• Responsible for the execution of disease and asset specific translational goals and developing long term translational strategy.
• Successfully managed key strategic projects and alliances with academic centers.
• Spearheaded collaborative initiatives internally to explore the mechanisms of resistance to T-cell directed therapies in the tumor microenvironment.
• Represented effectively the Translational Medicine function at Disease Strategy teams and Advisory boards ensuring alignment with the larger organization goals.
• Problem solving and managing biomarker scientists supporting five high priority registrational studies in cancer immunotherapy at BMS.

Hayward, California, US

• Developed and executed biomarker and diagnostic strategies for pivotal Phase 3 studies in advanced metastatic disease settings.
• Led biomarker sub-team, CDx project team, core member of global development team (clinical), global filing team (regulatory), and life cycle team (commercial).
• Successfully managed collaborations externally with pharma partners and internally with cross functional teams, prioritizing as well as delivering the translational science goals in a timely manner.

South San Francisco, California, US

• Led teams responsible for biomarker strategies in cancer immunotherapy clinical trials in different hematological malignancies (MM, NHL, AML and MDS).
• Responsible for the daily operations of a group of heme study biomarker leads.
• Achieved strategic and scientific success by creating an achievable long-term vision in multiple myeloma.
• Team building in a collaborative and inclusive work environment.
• Prioritized goals for success and focus efforts on the core mission e.g MRD efforts in MM.
• Contributed to development of clinical plans for indication selection, trial design, TPP and lifecycle strategies.

Stanford, CA, US

• Successfully identified novel biomarkers in MDS and deciphered their function.
• Unraveled the mechanisms underlying the onset of myeloid malignancies.
• Hands-on experience in pre-clinical research using murine and human hematopoietic stem cells.
• Trained and mentored research fellows and research associates.

Columbus, Ohio, US

• First genome-wide DNA methylation screening of leukemia patient samples.
• Identified first germ-line mutation in familial Chronic Lymphocytic Leukemia.
• Project leader, mentored graduate students and trained postdoctoral fellows.

Bethesda, MD, US

• Identified novel functions of transcriptional co-activator CIITA.
• Differential localization of transcription factors in the nucleus using cell biology techniques.